Wellcome Trust

Wellcome Trust. The Wellcome Trust is one of the world's largest charitable foundations, dedicated to improving health by supporting scientific research and addressing urgent global health challenges. Established through the bequest of pharmaceutical magnate Henry Wellcome, it funds discovery research across biology, medicine, and the humanities. The Trust operates with a substantial endowment and is known for its influential support of major scientific projects, public engagement through the Wellcome Collection, and advocacy for open science.

History

The Trust was established in 1936 following the death of its founder, Henry Wellcome, who amassed his fortune through the pharmaceutical company Burroughs Wellcome & Company. His will stipulated that his shares in the company should form a charitable trust for the advancement of medical and scientific research. Initially, the Trust's activities were managed by The Wellcome Foundation, which oversaw the commercial operations. A pivotal moment came in 1986 when the Trust sold a portion of its shares in Wellcome plc to the public, greatly increasing its capital. The full divestment was completed in 1995 following the acquisition of Wellcome plc by Glaxo to form GlaxoWellcome, providing the endowment that enables its contemporary global funding scale. Key historical figures in its development include early trustees like Henry Dale, a Nobel laureate in Physiology or Medicine.

Governance and structure

The Trust is governed by a Board of Governors, which sets its overall strategy and oversees its work. The board is chaired by former Prime Minister of Australia Julia Gillard and includes other prominent figures from science, policy, and business. Day-to-day leadership is provided by the Chief Executive Officer, a role held by John-Arne Røttingen. The organization is structured into directorates focusing on areas such as Science, Public Health, and Corporate Affairs. It maintains major offices in London and supports a global network of researchers and partners, including long-standing collaborations with institutions like the Francis Crick Institute and the African Academy of Sciences.

Funding and activities

With an endowment of over £38 billion, the Trust is a major funder of biomedical research and public health initiatives worldwide. Its funding strategy supports everything from early-career fellowships and investigator awards to large-scale strategic initiatives. A core principle is supporting high-risk, discovery-led science, often in areas like infectious disease, mental health, and climate change and health. The Trust is a leading proponent of open access publishing and data sharing, influencing policies at organizations like the National Institutes of Health and the European Commission. It also makes significant policy and advocacy investments, such as supporting research into antimicrobial resistance and pandemic preparedness.

Wellcome Collection

A major public-facing aspect of its work is the Wellcome Collection, a free museum and library located on Euston Road in London. Opened in 2007, it explores the connections between medicine, life, and art. The venue houses historical artifacts from Henry Wellcome's vast collections, contemporary exhibitions, the Wellcome Library, and a public events program. It has commissioned notable works from artists like Marc Quinn and Mona Hatoum, and its exhibitions often tour internationally, contributing to public discourse on science and society.

Notable initiatives and impact

The Trust has launched and funded numerous transformative initiatives. It was a founding partner and major funder of the Human Genome Project, contributing to the sequencing of one-third of the human genome. Other significant programs include the Wellcome Sanger Institute (formerly the Sanger Centre), a world-leading genomics research centre, and the Africa Health Research Institute in South Africa. It established the prestigious Wellcome Trust Awards for researchers. During the COVID-19 pandemic, it rapidly funded critical research, including the RECOVERY Trial led by the University of Oxford. Its funding has contributed to Nobel Prize-winning work, such as that of Peter Medawar on immunological tolerance and Fred Sanger for methods in DNA sequencing.

Category:Medical and health organizations based in London Category:Charities based in London Category:Biomedical research